Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Safety and Efficacy Evaluation of NH002 as a Contrast Agent in Subjects Undergoing Cardiac Echocardiography
Phase 3
Recruiting
- Conditions
- Cardiac Diseases
- Interventions
- Drug: NH002 (Perflutren Lipid Microspheres) Injectable Suspension
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Trust Bio-sonics, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT06815627
- Locations
- 🇨🇳
Keelung Chang Gung Memorial Hospital & Lovers Lake Branch, Keelung, Taiwan
🇨🇳China Medical University Hospital, Taichung, Taiwan
🇨🇳MacKay Memorial Hospital, Taipei, Taiwan
A Dose Ascending Study to Evaluate the Safety of NH002 as a Contrast Agent in Cardiac Echocardiography
Phase 1
Completed
- Conditions
- Cardiac Disease
- Interventions
- Drug: NH002 (Perflutren Lipid Microspheres) Injectable SuspensionDiagnostic Test: Echocardiogram
- First Posted Date
- 2019-12-04
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Trust Bio-sonics, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT04185246
- Locations
- 🇨🇳
Taipei Mackay Memorial Hospital, Taipei, Taiwan
🇨🇳Taipei Veterans General Hospital, Taipei, Taiwan
News
No news found